2024-04-012025-03-312025-03-31false12922926FINE FETTLE MEDICAL LTD2025-12-2486900falseiso4217:GBPxbrli:pure129229262024-03-31129229262025-03-31129229262024-04-012025-03-31129229262023-03-31129229262024-03-31129229262023-04-012024-03-3112922926bus:SmallEntities2024-04-012025-03-3112922926bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3112922926bus:FullAccounts2024-04-012025-03-3112922926bus:PrivateLimitedCompanyLtd2024-04-012025-03-3112922926core:WithinOneYear2025-03-3112922926core:AfterOneYear2025-03-3112922926core:WithinOneYear2024-03-3112922926core:AfterOneYear2024-03-3112922926core:ShareCapital2025-03-3112922926core:SharePremium2025-03-3112922926core:RevaluationReserve2025-03-3112922926core:OtherReservesSubtotal2025-03-3112922926core:RetainedEarningsAccumulatedLosses2025-03-3112922926core:ShareCapital2024-03-3112922926core:SharePremium2024-03-3112922926core:RevaluationReserve2024-03-3112922926core:OtherReservesSubtotal2024-03-3112922926core:RetainedEarningsAccumulatedLosses2024-03-3112922926core:LandBuildings2025-03-3112922926core:PlantMachinery2025-03-3112922926core:Vehicles2025-03-3112922926core:FurnitureFittings2025-03-3112922926core:OfficeEquipment2025-03-3112922926core:NetGoodwill2025-03-3112922926core:IntangibleAssetsOtherThanGoodwill2025-03-3112922926core:ListedExchangeTraded2025-03-3112922926core:UnlistedNon-exchangeTraded2025-03-3112922926core:LandBuildings2024-03-3112922926core:PlantMachinery2024-03-3112922926core:Vehicles2024-03-3112922926core:FurnitureFittings2024-03-3112922926core:OfficeEquipment2024-03-3112922926core:NetGoodwill2024-03-3112922926core:IntangibleAssetsOtherThanGoodwill2024-03-3112922926core:ListedExchangeTraded2024-03-3112922926core:UnlistedNon-exchangeTraded2024-03-3112922926core:LandBuildings2024-04-012025-03-3112922926core:PlantMachinery2024-04-012025-03-3112922926core:Vehicles2024-04-012025-03-3112922926core:FurnitureFittings2024-04-012025-03-3112922926core:OfficeEquipment2024-04-012025-03-3112922926core:NetGoodwill2024-04-012025-03-3112922926core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112922926core:ListedExchangeTraded2024-04-012025-03-3112922926core:UnlistedNon-exchangeTraded2024-04-012025-03-3112922926core:MoreThanFiveYears2024-04-012025-03-3112922926core:Non-currentFinancialInstruments2025-03-3112922926core:Non-currentFinancialInstruments2024-03-3112922926dpl:CostSales2024-04-012025-03-3112922926dpl:DistributionCosts2024-04-012025-03-3112922926core:LandBuildings2024-04-012025-03-3112922926core:PlantMachinery2024-04-012025-03-3112922926core:Vehicles2024-04-012025-03-3112922926core:FurnitureFittings2024-04-012025-03-3112922926core:OfficeEquipment2024-04-012025-03-3112922926dpl:AdministrativeExpenses2024-04-012025-03-3112922926core:NetGoodwill2024-04-012025-03-3112922926core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112922926dpl:GroupUndertakings2024-04-012025-03-3112922926dpl:ParticipatingInterests2024-04-012025-03-3112922926dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3112922926core:ListedExchangeTraded2024-04-012025-03-3112922926dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3112922926core:UnlistedNon-exchangeTraded2024-04-012025-03-3112922926dpl:CostSales2023-04-012024-03-3112922926dpl:DistributionCosts2023-04-012024-03-3112922926core:LandBuildings2023-04-012024-03-3112922926core:PlantMachinery2023-04-012024-03-3112922926core:Vehicles2023-04-012024-03-3112922926core:FurnitureFittings2023-04-012024-03-3112922926core:OfficeEquipment2023-04-012024-03-3112922926dpl:AdministrativeExpenses2023-04-012024-03-3112922926core:NetGoodwill2023-04-012024-03-3112922926core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112922926dpl:GroupUndertakings2023-04-012024-03-3112922926dpl:ParticipatingInterests2023-04-012024-03-3112922926dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112922926core:ListedExchangeTraded2023-04-012024-03-3112922926dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112922926core:UnlistedNon-exchangeTraded2023-04-012024-03-3112922926core:NetGoodwill2025-03-3112922926core:IntangibleAssetsOtherThanGoodwill2025-03-3112922926core:LandBuildings2025-03-3112922926core:PlantMachinery2025-03-3112922926core:Vehicles2025-03-3112922926core:FurnitureFittings2025-03-3112922926core:OfficeEquipment2025-03-3112922926core:AfterOneYear2025-03-3112922926core:WithinOneYear2025-03-3112922926core:ListedExchangeTraded2025-03-3112922926core:UnlistedNon-exchangeTraded2025-03-3112922926core:ShareCapital2025-03-3112922926core:SharePremium2025-03-3112922926core:RevaluationReserve2025-03-3112922926core:OtherReservesSubtotal2025-03-3112922926core:RetainedEarningsAccumulatedLosses2025-03-3112922926core:NetGoodwill2024-03-3112922926core:IntangibleAssetsOtherThanGoodwill2024-03-3112922926core:LandBuildings2024-03-3112922926core:PlantMachinery2024-03-3112922926core:Vehicles2024-03-3112922926core:FurnitureFittings2024-03-3112922926core:OfficeEquipment2024-03-3112922926core:AfterOneYear2024-03-3112922926core:WithinOneYear2024-03-3112922926core:ListedExchangeTraded2024-03-3112922926core:UnlistedNon-exchangeTraded2024-03-3112922926core:ShareCapital2024-03-3112922926core:SharePremium2024-03-3112922926core:RevaluationReserve2024-03-3112922926core:OtherReservesSubtotal2024-03-3112922926core:RetainedEarningsAccumulatedLosses2024-03-3112922926core:NetGoodwill2023-03-3112922926core:IntangibleAssetsOtherThanGoodwill2023-03-3112922926core:LandBuildings2023-03-3112922926core:PlantMachinery2023-03-3112922926core:Vehicles2023-03-3112922926core:FurnitureFittings2023-03-3112922926core:OfficeEquipment2023-03-3112922926core:AfterOneYear2023-03-3112922926core:WithinOneYear2023-03-3112922926core:ListedExchangeTraded2023-03-3112922926core:UnlistedNon-exchangeTraded2023-03-3112922926core:ShareCapital2023-03-3112922926core:SharePremium2023-03-3112922926core:RevaluationReserve2023-03-3112922926core:OtherReservesSubtotal2023-03-3112922926core:RetainedEarningsAccumulatedLosses2023-03-3112922926core:AfterOneYear2024-04-012025-03-3112922926core:WithinOneYear2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112922926core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3112922926core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3112922926core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112922926core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112922926core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112922926core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112922926core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112922926core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112922926core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112922926core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112922926core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112922926bus:Director12024-04-012025-03-3112922926bus:Director22024-04-012025-03-31

FINE FETTLE MEDICAL LTD

Registered Number
12922926
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

FINE FETTLE MEDICAL LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

FINDLAY, Karen King, Dr
LEACH, Tina

Registered Address

19 Stead Lane
Kirkheaton
Huddersfield
HD5 0JP

Registered Number

12922926 (England and Wales)
FINE FETTLE MEDICAL LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3299352
299352
Current assets
Stocks536339
Debtors4399399
Cash at bank and on hand1,8704,553
2,8055,291
Creditors amounts falling due within one year5(11,955)(11,140)
Net current assets (liabilities)(9,150)(5,849)
Total assets less current liabilities(8,851)(5,497)
Net assets(8,851)(5,497)
Capital and reserves
Called up share capital100100
Profit and loss account(8,951)(5,597)
Shareholders' funds(8,851)(5,497)
The financial statements were approved and authorised for issue by the Board of Directors on 24 December 2025, and are signed on its behalf by:
LEACH, Tina
Director
Registered Company No. 12922926
FINE FETTLE MEDICAL LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Tangible fixed assets and depreciation
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Reducing balance (%)Straight line (years)
Plant and machinery15-
Office Equipment-3
Stocks and work in progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell.
2.Average number of employees

20252024
Average number of employees during the year00
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 24590350940
At 31 March 25590350940
Depreciation and impairment
At 01 April 24238350588
Charge for year53-53
At 31 March 25291350641
Net book value
At 31 March 25299-299
At 31 March 24352-352
4.Debtors: amounts due within one year

2025

2024

££
Other debtors399399
Total399399
5.Creditors: amounts due within one year

2025

2024

££
Other creditors11,95511,140
Total11,95511,140
6.Directors advances, credits and guarantees
Included within creditors: amounts falling due within one year were loans from the directors of £11,320 (2023: £10,526). The loans were interest free, with no fixed date for repayment.